Base-edited cynomolgus monkeys mimic core symptoms of STXBP1 encephalopathy-Reference-Cited by-同舟云学术

Base-edited cynomolgus monkeys mimic core symptoms of STXBP1 encephalopathy

Published:2022-06 Issue:6 Volume:30 Page:2163-2175
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Lu Zongyang,He Siting,Jiang Jian,Zhuang Ling,Wang Yan,Yang Guang,Jiang Xiaoyu,Nie Yanhong,Fu Jiqiang,Zhang Xiaotong,Lu Yong,Bian Xinyan,Chang Hung-Chun,Xiong Zhiqi,Huang Xingxu,Liu Zhen,Sun Qiang

Funder

National Postdoctoral Program for Innovative Talents

Shanghai Municipal Government

National Natural Science Foundation of China

Chinese Academy of Sciences

Ministry of Human Resources and Social Security of the People's Republic of China

Science and Technology Commission of Shanghai Municipality

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference66 articles.

1. STXBP1 encephalopathies: clinical spectrum, disease mechanisms, and therapeutic strategies;Abramov;J. Neurochem.,2020

2. STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy;Stamberger;Neurology,2016

3. Mechanism-based rescue of Munc18-1 dysfunction in varied encephalopathies by chemical chaperones;Guiberson;Nat. Commun.,2018

4. Munc18-1 haploinsufficiency impairs learning and memory by reduced synaptic vesicular release in a model of Ohtahara syndrome;Orock;Mol. Cell Neurosci.,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in STXBP1 encephalopathy research and translational opportunities;Journal of Neurorestoratology;2024-09

2. Early blood immune molecular alterations in cynomolgus monkeys with a PSEN1 mutation causing familial Alzheimer's disease;Alzheimer's & Dementia;2024-07-07

3. What we have learned from non-human primates as animal models of epilepsy;Epilepsy & Behavior;2024-05

4. STXBP1: fast-forward to a brighter future – a patient organization perspective;Therapeutic Advances in Rare Disease;2024-01